Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1290271000001114 | Faricimab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1290431000001113 | Faricimab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Faricimab | Is a | Monoclonal antibody | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Faricimab 28.8mg/0.24ml solution for injection vials | Has specific active ingredient | True | Faricimab | Inferred relationship | Existential restriction modifier | |
| Vabysmo 28.8mg/0.24ml solution for injection vials (Roche Products Ltd) 1 vial | Has specific active ingredient | True | Faricimab | Inferred relationship | Existential restriction modifier | |
| Faricimab 28.8mg/0.24ml solution for injection vials 1 vial | Has specific active ingredient | True | Faricimab | Inferred relationship | Existential restriction modifier | |
| Vabysmo 28.8mg/0.24ml solution for injection vials (Roche Products Ltd) | Has specific active ingredient | True | Faricimab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR